Search Results
Results found for "pain research"
- "Solving financial puzzles feels just like solving scientific ones," says Joe St. Germain from Company Launch Partners. Behind every successful research organization, there is a rock-solid operations team. Don’t miss this rare conversation bridging science, structure, and strategy with Chuck DeWeese & Joe St. Germain. ✳️ Tune in now: Ep 165 with Chuck DeWeese & Joe St. Germain #gpcr #DrGPCR #ScienceStartup | Dr. GPCR Ecosystem
Behind every successful research organization, there is a rock-solid operations team. Germain from Company Launch Partners.Behind every successful research organization, there is a rock-solid
- 🔥 New Course Alert! “Development of GPCR Ligands as Therapeutic Drugs” with Dr. Terry Kenakin is here! Spots are filling up fast—Premium Members get 25% off! This advanced course is exclusively available in the Ecosystem, so don’t miss your chance to learn from the best. 🔹 Secure your spot now! 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy #drugdiscovery #research | Dr. GPCR Ecosystem
event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy #drugdiscovery #research event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy #drugdiscovery #research
- New Episode Alert! 🎙️ Ep. 163 of the Dr. GPCR Podcast is here! 🚀 This time, we sit down with Dr. Dmitry Veprintsev to discuss the importance of asking the right GPCR questions. Whether you're a researcher, student, or GPCR enthusiast, this episode is packed with insights that will challenge how you think about your experiments. ✳️Tune in at https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ep-163-with-dr.-dmitry- #DrGPCR #GPCRPodcast #Pharmacology #DrugDiscovery #Biotech #GPCRs | Dr. GPCR Ecosystem
Whether you're a researcher, student, or GPCR enthusiast, this episode is packed with insights that will Whether you're a researcher, student, or GPCR enthusiast, this episode is packed with insights that will
- GPCRs regulate key biological processes, but how exactly do inhibitory Gαi proteins control signal transduction beyond adenylyl cyclase suppression? New research sheds light on these pathways! ✨ Want to learn more? Did you know that we work hard to bring you the most recent GPCR News, weekly? Catch up today in the Ecosystem using your free site membership! | Dr. GPCR Ecosystem
New research sheds light on these pathways! ✨ Want to learn more? New research sheds light on these pathways! ✨ Want to learn more?
- Dr. Simone Prömel & Dr. Ines Liebscher | Dr. GPCR Ecosystem
Simone Prömel on the web Prömel Lab Pubmed Researchgate Twitter Dr. GPCR Ecosystem About Dr. Ines Liebscher on the web Website LinkedIn Researchgate Dr. GPCR Ecosystem Enjoying the Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- 🚀 Ready to dive into the world of GPCR drug development? Join Dr. Terry Kenakin for the 4-week course “Development of GPCR Ligands as Therapeutic Drugs”! Get exclusive access to expert lectures, recordings, reading materials, and even a private call with Dr. Kenakin himself! Don’t miss this chance to level up your knowledge. 🔹 Spots are limited—save yours now! 👉 https://www.ecosystem.drgpcr.com/event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy #drugdiscovery #research | Dr. GPCR Ecosystem
event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy #drugdiscovery #research event-details-registration/development-of-gpcr-ligands-as-therapeutic-drugs #gpcr #drgpcr #pharmacolgy #drugdiscovery #research
- 🎯 Crack the code of GPCR ligand development! In case you haven’t heard, Dr. Terry Kenakin is hosting a 4-week course on GPCR drug development—and registration closes in 3 days! ⚠️ What you’ll learn: ✅ Drug absorption, metabolism & clearance ✅ PK-PD modeling & therapeutic profiles ✅ Early safety assessments & toxicity risks 📌 Limited spots—sign up before March 18th! 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Ecosystem #GPCR #DrGPCR #Pharma #Biotech #Research | Dr. GPCR Ecosystem
GPCR Ecosystem #GPCR #DrGPCR #Pharma #Biotech #Research Published on March 15, 2025 Category Dr. GPCR Ecosystem #GPCR #DrGPCR #Pharma #Biotech #Research Previous Next Recent Articles
- Dr. Brian Arey | Dr. GPCR Ecosystem
Brian Arey on the web LinkedIn ResearchGate Pubmed Dr. GPCR Ecosystem Enjoying the Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- Dr. Françoise Bachelerie | Dr. GPCR Ecosystem
Françoise Bachelerie on the web INSERM ResearchGate SciSpace Loop LinkedIn Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- Dr. Brian Arey | Dr. GPCR Ecosystem
Brian Arey on the web LinkedIn ResearchGate Pubmed Dr. GPCR Ecosystem Enjoying the Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- Did you know that GPR180 helps regulate lipid metabolism and may play a role in preventing obesity? recent study shows that overexpression of GPR180 in adipose tissue improves lipid metabolism and protects against HFD-induced obesity, while its knockout worsens lipid accumulation. This finding highlights GPR180 as a potential therapeutic target for metabolic disorders! Catch up on this exciting research in the Ecosystem today! 🏆📖 You’ll need to register, but don’t worry—it’s free! ➡️https://www.ecosystem.drgpcr.com/gpcrs-in-cardiology-endocrinology-and-taste/gpr180-reduces-adiposity-by-inhibiting-lipogenesis-and-fatty-acid-uptake-in-adipocytes #gpcr #drgpcr #metabolism #obesity | Dr. GPCR Ecosystem
Catch up on this exciting research in the Ecosystem today! Catch up on this exciting research in the Ecosystem today!
- New strategic partnership alert! 🚀 Dr.GPCR x Celtarys are teaming up to revolutionize fluorescent ligand development for GPCR research. Get custom, fast, and functional ligands backed by real scientists solving real assay problems. 🧪 “We don’t just deliver compounds. We solve assay problems.” – Dr. Maria Majellaro, CSO, Celtarys Listen to Ep. 168 now and meet your new assay partner 😉 ✳️ https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ep-168-with-dr.-maria-majellaro-from-celtarys #GPCRdrugDiscovery #FluorescentLigands #DrGPCR #BiotechTools #AssayDevelopment | Dr. GPCR Ecosystem
🚀 Dr.GPCR x Celtarys are teaming up to revolutionize fluorescent ligand development for GPCR research 🚀 Dr.GPCR x Celtarys are teaming up to revolutionize fluorescent ligand development for GPCR research
- Ever wondered how we perceive bitterness? 👅🔬 Researchers have unveiled the cryo-EM structure of TAS2R14, the most promiscuous bitter taste receptor, bound to the drug flufenamic acid (FFA) and its signaling partner gustducin! 🌟 This discovery reveals an unusual dual binding mode of FFA and offers tools for site-targeted compound design. 🧪✨ Learn more about this exciting breakthrough in bitter taste signaling. | Dr. GPCR Ecosystem
👅🔬 Researchers have unveiled the cryo-EM structure of TAS2R14, the most promiscuous bitter taste receptor 👅🔬 Researchers have unveiled the cryo-EM structure of TAS2R14 , the most promiscuous bitter taste receptor
- A new study from the Hudson Lab at the University of Glasgow shows that the FFA receptor antagonist AH7614 is actually an inverse agonist - suppressing fat cell formation, boosting lipolysis and reducing glucose uptake. Explore how targeting FFA4 could help fight metabolic disorders. Catch up with the latest research conducted in the Hudson lab in Ep. 161 of the Dr. GPCR Podcast. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com/gpcrs-in-cardiology-endocrinology-and-taste/inverse-agonism-of-the-ffa4-free-fatty-acid-receptor-controls-both-adipogenesis-and-mature-adipocyte-function #GPCR #drGPCR #FFA4 #metabolism #adipocytes” | Dr. GPCR Ecosystem
Catch up with the latest research conducted in the Hudson lab in Ep. 161 of the Dr. GPCR Podcast. Catch up with the latest research conducted in the Hudson lab in Ep. 161 of the Dr. GPCR Podcast.
- What if you could map GPCR-RAMP interactions across the entire superfamily in a single experiment? That’s precisely what Dr. Kotliar from the Sakmar lab made possible! In Ep.167 of the Dr. GPCR Podcast, we chat with Drs. Tom Sakmar and Ilana Kotliar about how their lab developed: A multiplexed Luminex assay to screen hundreds of interactions at once A 220-clone DUET-tagged GPCR library, available on Addgene An online interface to search GPCR-RAMP data and antibody validations This is open-access science at its best, built for the GPCR research community. ✳️ Listen to the episode: Ep 167 with Drs. Tom Sakmar & Ilana Kotliar #GPCRresearch #DrGPCRecosystem #GPCRdrugdiscovery #GPCRtrainingprogram #GPCRpodcast | Dr. GPCR Ecosystem
interactions at once A 220-clone DUET-tagged GPCR library, available on Addgene An online interface to search GPCR-RAMP data and antibody validations This is open-access science at its best, built for the GPCR research interactions at once A 220-clone DUET-tagged GPCR library, available on Addgene An online interface to search GPCR-RAMP data and antibody validations This is open-access science at its best, built for the GPCR research
- Dr. Tobi Langenhan | Dr. GPCR Ecosystem
to the University of Oxford on a 4-year Wellcome Trust Scholarship in Neuroscience, through which I gained How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
provide an ideal case study for quantitative, and multi‐scale integration of these amounts of data to gain How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- Dr. Robert F. Bruns | Dr. GPCR Ecosystem
Bruns on the web ResearchGate LinkedIn Dr. GPCR Enjoying the Dr. GPCR Podcast? Leave a Review. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- Dr. John Janetzko | Dr. GPCR Ecosystem
Over the course of my graduate work, I gained experience with structural mass spectrometry and protein Besides research, I am passionate about teaching, science communication and making research more inclusive John Janetzko on the web Stanford University Stanford Medicine Google Scholar Personal Website ResearchGate importance of adaptability, as unexpected situations like the Covid-19 pandemic can affect the job searching How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Full Agenda Session V Structural mechanisms of AGPCR signaling and function Structural Determinants Of GAIN Unveiling the GPS Cleavage Mechanism in ADGRL1 with QM/MM Florian Seufert Structural Determinants Of GAIN ADGRs are autoproteo-lytically cleaved at the GPCR proteolysis site (GPS), an HXS/T motif within the GAIN We de-termined the crystal structure of the human ADGRB2/BAI2 hormone receptor (HormR) and GAIN domains Florian Seufert on the web LinkedIn ResearchGate < Previous Session Next Session >
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
De-risk decisions: gain expert strategic guidance on study design, timelines, and partner selection before credible GPCR CROs and expert consultants 📚 Train and upskill your team with specialized programs 📢 Gain Gain confidence and direction with a customized roadmap aligned to your biotech’s goals and timeline Learn how to apply GPCR concepts and data to real-world research and development. Gain clarity and direction to move your biotech forward—faster and smarter. → Explore Timeline Strategy
- Illuminating Functional Selectivity and Allosterism at GPCRs.
Stéphane Laporte is a Professor of Medicine, and the Director of Research of the Division of Endocrinology He has received many awards, including a Canada Research Chair, FRSQ scholarships and the CDA/CSEM/Merck His expertise is in molecular pharmacology and his research program focuses on the molecular and cellular His research program also studies the allosteric, biased signalling regulation of GPCR and has contributed The Canadian Institutes for Health Research and March of Dimes currently support his research."
- Nicole Perry-Hauser | Dr. GPCR Ecosystem
Podcast Strategic Partners Nicole Perry-Hauser About Nicole (Nicki) Perry-Hauser I am a postdoctoral research fellow endeavoring to build a productive, independent scientific research career in adhesion G protein-coupled My long-term research interests involve resolving signaling pathways downstream of aGPCRs and establishing Nicole (Nicki) Perry-Hauser on the web LinkedIn Research Gate Pubmed Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- Dr. Kathleen Caron | Dr. GPCR Ecosystem
coupled receptors and receptor activity modifying proteins in vascular biology, the Caron laboratory has gained How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- GPCR Weekly News | Dr. GPCR Ecosystem
Stay ahead with the latest research breakthroughs, industry updates, job opportunities, and upcoming GPCR Weekly News - Your Hub for GPCR Research, Industry Updates, Jobs & Events Delivered straight to Latest Research Breakthrough discoveries, new publications, and cutting-edge GPCR research insights. of what you'll find in our latest newsletter How Schild Analysis Protects Your Conclusions in GPCR Research Valid until canceled Join Premium Now 🎓 Full GPCR University + 🔬 200+ expert talks 🗞️ Weekly research
- Session IV | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Mihaylov " I am a postdoctoral researcher in the kinases and brain development laboratory led by Dr Sila My main topics were protein biochemistry, Drosophila husbandry, and genetics. Since then, I have broadened my horizons with many more techniques in vivo and in vitro, with a main
- University Pricing | Dr. GPCR Ecosystem
All these benefits are designed to enhance your research experience and keep you informed about the latest Accelerate Your GPCR Research Join a global community of scientists transforming how GPCR discoveries One insight, one connection, one ‘aha’ moment — can save months of research time. opportunities, and tools to accelerate GPCR-related research and career growth. Ready to Advance Your GPCR Research?
- Dr. Gunnar Schulte | Dr. GPCR Ecosystem
Gunnar Schulte Gunnar Schulte is a Professor in receptor pharmacology and research group leader for the Gunnar Schulte is also the scientific secretary of the Swedish Society for Medical Research (SSMF) and General Research Interest: The focus in the Schulte lab is on Frizzled signaling and pharmacology aiming Most importantly my research team tries to understand underlying mechanisms of WNT-receptor interaction How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- Dr. Patrick Sexton | Dr. GPCR Ecosystem
Patrick Sexton Patrick Sexton is a Professor of Pharmacology, National Health and Medical Research Council of Australia Senior Principal Research Fellow, and Director of the Australian Research Council Centre He is a 2021 Clarivate Analytics Highly Cited Researcher in two disciplines: Pharmacology & Toxicology Society), Vane Medal (BPS), Gordon Hammes Lectureship Award (American Chemical Society) and the GSK Research How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research
- Dr. Stephane Angers | Dr. GPCR Ecosystem
Angers established his independent research program in the Department of Pharmaceutical Sciences at the He is the recipient of the Canada Research Chair in Functional Architecture of Signal Transduction. His research program is developed to understand the signaling mechanisms underlying the Wnt and Hedgehog Angers was named Director of the Donnelly Centre of Cellular and Biomolecular Research at the University of Toronto, an internationally recognized Research Institute bringing together multidisciplinary teams















